ALX Oncology Holdings Inc. (ALXO) — Dilution Risk Analysis
Current Snapshot
ALX Oncology Holdings Inc. (ALXO) has a DilutionWatch score of 40/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 40/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 1, 3 2, 4 7.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-4488-xbrl_warrant |
| 3 | 2026-04-17 | 0001193125-26-161540 |
| 4 | 2026-04-17 | 0001193125-26-161557 |
| 4 | 2026-04-17 | 0001193125-26-161558 |
| 4 | 2026-03-23 | 0001193125-26-119703 |
| 4 | 2026-03-23 | 0001193125-26-119705 |
| 3 | 2026-03-05 | 0001193125-26-093894 |
| 4 | 2026-03-05 | 0001193125-26-093913 |
| 4 | 2026-02-20 | 0001193125-26-061313 |
| 4 | 2026-02-19 | 0001193125-26-060037 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $117,800,000 | Source |
| Cash runway | 15 months | Source |
| Three-year share count growth | 177.56% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 40/10) Source
- Cash Runway
- 15 months Source
- ATM Offering Capacity Remaining
- $117,800,000 Source
- Share Count Growth (3-Year)
- 177.56% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.